NHS medicine safety data has revealed 216 deaths and around 18,000 severe reactions in the UK linked to weight-loss injections such as Mounjaro and Wegovy, with fatalities reported to have risen by 300 per cent over the past year. The figures have intensified concerns about the safety of these increasingly popular jabs, which are used by growing numbers of people both on prescription and privately, raising questions about how closely dosing and side effects are being monitored.

The report highlights the case of a woman who died after increasing her Mounjaro dose, illustrating fears that escalating doses without adequate medical supervision may heighten risks. The sharp year-on-year rise in fatalities has prompted renewed calls for tighter oversight of the drugs' use, particularly as demand continues to surge amid their popularity as a weight-loss treatment.